首页> 外文OA文献 >HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-PD-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment

【2h】

HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-PD-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment

机译：HDAC抑制剂CG-745，通过调节免疫微环境来增强抗PD-1免疫检查点抑制剂的抗癌作用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Young-Dae Kim; Sang-Min Park; Hae Chan Ha; A Reum Lee; Heeyoung Won; Hyunju Cha; Sangsook Cho; Joong Myung Cho;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-PD-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment [J] . Young-Dae Kim, Sang-Min Park, Hae Chan Ha, Journal of Cancer . 2020,第14期

机译：HDAC抑制剂CG-745，通过调节免疫微环境来增强抗PD-1免疫检查点抑制剂的抗癌作用
2. Immune checkpoint inhibitor (anti-CTLA-4, anti-PD-1) therapy alone versus immune checkpoint inhibitor (anti-CTLA-4, anti-PD-1) therapy in combination with anti-RANKL denosumuab in malignant melanoma: a retrospective analysis at a tertiary care center [J] . Afzal Muhammad Z., Shirai Keisuke Melanoma research . 2018,第4期

机译：免疫检查点抑制剂（抗CTLA-4，抗PD-1）治疗与免疫检查点抑制剂（抗CTLA-4，抗PD-1）治疗组合在恶性黑色素瘤中的抗Rankl Denosumuab组合：回顾性分析在一个第三级护理中心
3. ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma [J] . Hailong Sheng, Yan Huang, Yazhi Xiao, Journal for ImmunoTherapy of Cancer . 2020,第1期

机译：ATR抑制剂AZD6738通过提高肝细胞癌肿瘤免疫微环境来增强放射疗法和免疫检查点抑制剂的抗肿瘤活性
4. The Biologic Scaffold Immune Microenvironment Inhibits Tumor Formation and Synergizes with Immunotherapy [C] . Matthew T. Wolf, Sudipto Ganguly, Radhika Narain, Society for Biomaterials annual meeting and exposition . 2019

机译：生物支架免疫微环境抑制肿瘤形成并与免疫疗法协同作用。
5. Immune-Related Adverse Events in Cancer Patients Being Treated with Immune Checkpoint Inhibitors [D] . Byrne, Margaret M. 2021

机译：用免疫检查点抑制剂治疗癌症患者免疫相关不良事件
6. HDAC Inhibitor CG-745 Enhances the Anti-Cancer Effect of Anti-PD-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment [O] . Young-Dae Kim, Sang-Min Park, Hae Chan Ha, 2020

机译：HDAC抑制剂CG-745通过调节免疫微环境增强抗PD-1免疫检查点抑制剂的抗癌作用
7. Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells [O] . Tessa Knox, Eva Sahakian, Debarati Banik, 2019

机译：选择性HDAC6抑制剂通过降低巨噬细胞的抗炎表型和肿瘤细胞中免疫抑制蛋白的抗炎表型来改善抗PD-1免疫检查点阻断治疗

HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-PD-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment

著录项

引文网络

相似文献

相关主题

期刊订阅